ALT – Altimmune Inc
Name : Altimmune, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.0000
EPSttm :
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ALT
#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ALT
&conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]
Float Short %
28.7
Margin Of Safety %
Put/Call OI Ratio
0.24
EPS Next Q Diff
-0.05
EPS Last/This Y
0.21
EPS This/Next Y
-0.25
Price
3.92
Target Price
17.75
Analyst Recom
1.67
Performance Q
-17.09
Relative Volume
0.62
Beta
0.01
Ticker: ALT
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-09-08 | ALT | 3.7 | 0.18 | 0.39 | 198096 |
| 2025-09-09 | ALT | 3.78 | 0.19 | 0.15 | 199497 |
| 2025-09-10 | ALT | 3.67 | 0.19 | 0.31 | 201371 |
| 2025-09-11 | ALT | 3.68 | 0.19 | 0.31 | 203752 |
| 2025-09-12 | ALT | 3.63 | 0.19 | 0.14 | 204919 |
| 2025-09-15 | ALT | 3.59 | 0.19 | 0.64 | 203794 |
| 2025-09-16 | ALT | 3.64 | 0.19 | 0.98 | 206493 |
| 2025-09-17 | ALT | 3.57 | 0.192621466393 | 0.58887677208288 | 207441 |
| 2025-09-18 | ALT | 3.86 | 0.19 | 0.08 | 208581 |
| 2025-09-22 | ALT | 3.95 | 0.24 | 0.11 | 169039 |
| 2025-09-23 | ALT | 3.8 | 0.23 | 0.09 | 177076 |
| 2025-09-24 | ALT | 3.93 | 0.23 | 0.27 | 179504 |
| 2025-09-25 | ALT | 3.92 | 0.22 | 0.38 | 194043 |
| 2025-09-26 | ALT | 3.98 | 0.23 | 0.15 | 199893 |
| 2025-09-29 | ALT | 3.79 | 0.23 | 0.90 | 194248 |
| 2025-09-30 | ALT | 3.77 | 0.24 | 0.45 | 196847 |
| 2025-10-01 | ALT | 3.86 | 0.24 | 0.11 | 197514 |
| 2025-10-02 | ALT | 3.92 | 0.24 | 0.15 | 203965 |
| 2025-10-03 | ALT | 3.9 | 0.24 | 0.12 | 205054 |
| 2025-10-06 | ALT | 4.01 | 0.24 | 0.09 | 201615 |
| 2025-10-07 | ALT | 3.92 | 0.24 | 0.08 | 202255 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-09-08 | ALT | 3.71 | 16.2 | -75.7 | -1.13 |
| 2025-09-09 | ALT | 3.78 | 16.2 | -88.8 | -1.13 |
| 2025-09-10 | ALT | 3.67 | 16.2 | -72.1 | -1.13 |
| 2025-09-11 | ALT | 3.69 | 16.2 | -83.6 | -1.13 |
| 2025-09-12 | ALT | 3.63 | 16.2 | -76.0 | -1.13 |
| 2025-09-15 | ALT | 3.59 | 16.2 | -77.5 | -1.13 |
| 2025-09-16 | ALT | 3.63 | 16.2 | -85.8 | -1.13 |
| 2025-09-17 | ALT | 3.57 | 16.2 | -76.4 | -1.13 |
| 2025-09-18 | ALT | 3.86 | 16.2 | -112.1 | -1.13 |
| 2025-09-19 | ALT | 3.77 | 16.2 | -74.3 | -1.13 |
| 2025-09-22 | ALT | 3.96 | 16.2 | -99.2 | -1.13 |
| 2025-09-23 | ALT | 3.80 | 16.2 | -69.0 | -1.13 |
| 2025-09-24 | ALT | 3.93 | 16.2 | -94.8 | -1.13 |
| 2025-09-25 | ALT | 3.92 | 16.2 | -86.4 | -1.13 |
| 2025-09-26 | ALT | 4.00 | 16.2 | -88.5 | -1.13 |
| 2025-09-29 | ALT | 3.78 | 16.2 | -64.8 | -1.13 |
| 2025-09-30 | ALT | 3.77 | 16.2 | -80.4 | -1.13 |
| 2025-10-01 | ALT | 3.87 | 16.2 | -90.6 | -1.13 |
| 2025-10-02 | ALT | 3.93 | 16.2 | -87.7 | -1.13 |
| 2025-10-03 | ALT | 3.91 | 16.2 | -80.2 | -1.13 |
| 2025-10-06 | ALT | 4.02 | 16.2 | -90.1 | -1.13 |
| 2025-10-07 | ALT | 3.92 | 16.2 | -74.6 | -1.13 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-09-08 | ALT | 1.29 | -1.38 | 29.13 |
| 2025-09-09 | ALT | 1.29 | -1.38 | 29.13 |
| 2025-09-10 | ALT | 1.29 | -1.38 | 29.13 |
| 2025-09-11 | ALT | 1.29 | -1.38 | 30.63 |
| 2025-09-12 | ALT | 1.29 | -1.38 | 30.63 |
| 2025-09-15 | ALT | 0.12 | -1.30 | 30.63 |
| 2025-09-16 | ALT | 0.12 | -1.30 | 30.63 |
| 2025-09-17 | ALT | 0.12 | -1.30 | 30.63 |
| 2025-09-18 | ALT | 0.12 | -1.30 | 30.63 |
| 2025-09-19 | ALT | 0.00 | -1.30 | 30.63 |
| 2025-09-22 | ALT | 0.00 | -1.30 | 30.63 |
| 2025-09-23 | ALT | 0.00 | -1.30 | 30.63 |
| 2025-09-24 | ALT | 0.00 | -1.30 | 30.63 |
| 2025-09-25 | ALT | 0.00 | -1.30 | 28.70 |
| 2025-09-26 | ALT | 0.00 | -1.30 | 28.70 |
| 2025-09-29 | ALT | 0.00 | -1.28 | 28.70 |
| 2025-09-30 | ALT | 0.00 | -1.28 | 28.70 |
| 2025-10-01 | ALT | 0.00 | -1.28 | 28.70 |
| 2025-10-02 | ALT | 0.00 | -1.28 | 28.70 |
| 2025-10-03 | ALT | 0.00 | -1.28 | 28.70 |
| 2025-10-06 | ALT | 0.00 | -0.56 | 28.70 |
| 2025-10-07 | ALT | 0.00 | -0.56 | 28.70 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ALT
589 360 ]
Last Quarter Act. EPS
-0.27
Avg. EPS Est. Current Quarter
-0.27
Avg. EPS Est. Next Quarter
-0.32
Insider Transactions
Institutional Transactions
-0.56
Beta
0.01
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
23
Growth Score
23
Sentiment Score
40
Actual DrawDown %
84.1
Max Drawdown 5-Year %
-91.2
Target Price
17.75
P/E
Forward P/E
PEG
P/S
17342.47
P/B
2.07
P/Free Cash Flow
EPS
-1.18
Average EPS Est. Cur. Y
-1.13
EPS Next Y. (Est.)
-1.38
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-438730
Relative Volume
0.62
Return on Equity vs Sector %
-79.6
Return on Equity vs Industry %
-65.9
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
-74.6
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ALT
589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ALT
589 450 ]
Altimmune, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune Inc Stock Price stock today
news today ALT – Altimmune Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune Inc yahoo finance google finance
stock history ALT – Altimmune Inc invest stock market
stock prices ALT
premarket after hours
ticker ALT
fair value insiders trading
